Safety and efficacy of biosimilar filgrastim in patients with lung cancer undergoing neutropenia-inducing chemotherapy: A sub-analysis of the NEXT study

被引：0
|
作者：
Kamioner, D. [1 ]
Lepretre, S. [2 ]
Maloisel, F. [3 ]
Berthou, C. [4 ]
Albrand, H. [5 ]
机构：
[1] Hop Prive Ouest Parisien, Oncol, Trappes, France
[2] Henri Becquerel Hosp, Hematol, Rouen, France
[3] St Anne Clin, Hematol & Oncol, Strasbourg, France
[4] Hop Morvan, Hematol, Brest, France
[5] Hospira France, Hospira, Meudon, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30592-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1501
引用
收藏
页码：S204 / S205
页数：3
相关论文
共 50 条
  • [31] A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer
    Waller, Cornelius F.
    Semiglazov, Vladimir F.
    Tjulandin, Sergei
    Bentsion, Dmitry
    Chan, Stephen
    Challand, Rodeina
    ONKOLOGIE, 2010, 33 (10): : 504 - 511
  • [32] Filgrastim biosimilar for neutropenia in gynecological cancer patients receiving chemotherapy: a prospective, single-center, non-randomized, open trial
    Sato, Y.
    Sumimoto, T.
    Tsushita, H.
    Nakahara, R.
    Matsumoto, H.
    Itoh, H.
    PHARMAZIE, 2018, 73 (08): : 486 - 488
  • [33] Prophylaxis of chemotherapy-induced febrile neutropenia with biosimilar filgrastim: Description of patients, treatment patterns and outcomes in the MONITOR-GCSF study in the breast cancer cohort
    Gascon, Pere
    Aapro, Matti
    Ludwig, Heinz
    Boccadoro, Mario
    Bokemeyer, Carsten
    Turner, Matthew
    Muenzberg, Michael
    Abraham, Ivo
    Denhaerynck, Kris
    MacDonald, Karen
    CANCER RESEARCH, 2015, 75
  • [34] RELATIVE DOSE INTENSITY OF CHEMOTHERAPY AND PREVENTION OF FEBRILE NEUTROPENIA WITH BIOSIMILAR FILGRASTIM: A MULTICENTRIC OBSERVATIONAL STUDY OF 633 LYMPHOID MALIGNANCY PATIENTS (THE ZOHE STUDY)
    Rodon, P.
    Damaj, G.
    Salles, G.
    Bareau, B.
    Gasnereau, I.
    Aubron-Olivier, C.
    Haioun, C.
    Solal-Celigny, P.
    HAEMATOLOGICA, 2015, 100 : 465 - 466
  • [35] Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study
    Kim, Hyung-Don
    Lee, Jong Seok
    Park, Young Soo
    Yook, Jeong Hwan
    Noh, Sung Hoon
    Park, Young-Kyu
    Kim, Young-Woo
    Oh, Sang Cheul
    Kim, Jong Gwang
    Ryu, Min-Hee
    Cheong, Jae-Ho
    Kim, HyunKi
    Lim, Joon Seok
    Lee, Jae-Hyuk
    Heo, Suk Hee
    Kim, Jin Young
    Heo, Mi Hwa
    Park, Young Iee
    Kim, In-Ho
    Kang, Yoon-Koo
    GASTRIC CANCER, 2022, 25 (06) : 1039 - 1049
  • [36] Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study
    Hyung-Don Kim
    Jong Seok Lee
    Young Soo Park
    Jeong Hwan Yook
    Sung Hoon Noh
    Young-Kyu Park
    Young-Woo Kim
    Sang Cheul Oh
    Jong Gwang Kim
    Min-Hee Ryu
    Jae-Ho Cheong
    HyunKi Kim
    Joon Seok Lim
    Jae-Hyuk Lee
    Suk Hee Heo
    Jin Young Kim
    Mi Hwa Heo
    Young Iee Park
    In-Ho Kim
    Yoon-Koo Kang
    Gastric Cancer, 2022, 25 : 1039 - 1049
  • [37] Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: a retrospective analysis
    Gu, Xiaodong
    Zhang, Yiping
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 7841 - 7846
  • [38] Efficacy and safety of pegteograstim and pegfilgrastim on chemotherapy-induced neutropenia in ovary cancer patients
    Kim, M. K.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 357 - 357
  • [39] Treatment patterns and outcomes in patients with breast cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study
    Aapro, M.
    Krendyukov, A.
    Krivtsova, N.
    Gascon, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S53 - S53
  • [40] Prophylaxis of chemotherapy-induced febrile neutropenia with biosimilar filgrastim: Description of patients, treatment patterns and outcomes in the MONITOR-GCSF Study in Germany
    Bokemeyer, C.
    Ottillinger, B.
    Bulenda, D.
    Turner, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 161 - 161
12345